Table Graph
      published meta-analysis   sensitivity analysis   studies

placebo in COVID 19 outpatients - Summary of results

OutcomeTE95% CInkI2ROBPub. bias viral clearance detailed resultsQ-PROTECT (HCQ/AZI vs PLACEBO), 2020 (REV) 1.16 [0.62; 2.18] 1.16[0.62; 2.18]Q-PROTECT (HCQ/AZI vs PLACEBO), 2020 (REV)10%299NAnot evaluable viral clearance by day 14detailed resultsQ-PROTECT (HCQ/AZI vs PLACEBO), 2020 (REV) 1.82 [1.07; 3.11] 1.82[1.07; 3.11]Q-PROTECT (HCQ/AZI vs PLACEBO), 2020 (REV)10%292NAnot evaluable viral clearance by day 7detailed resultsQ-PROTECT (HCQ/AZI vs PLACEBO), 2020 (REV) 1.16 [0.62; 2.18] 1.16[0.62; 2.18]Q-PROTECT (HCQ/AZI vs PLACEBO), 2020 (REV)10%299NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-06-04 09:04 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 97 - treatments: 650 - roots T: 650

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons